+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Middle East and Africa DNA Vaccines Market 2019-2027

  • ID: 4827814
  • Report
  • Region: Africa, Middle East
  • 72 pages
  • Triton Market Research
UP TO OFF
until Jan 31st 2020
1 of 3

FEATURED COMPANIES

  • Astellas Pharma, Inc.
  • Eli Lilly And Company
  • Eurogentec S.A.
  • Glaxosmithkline, Inc.
  • Merck & Co.
  • Novartis AG
  • MORE
Market Outlook

The DNA vaccines market in the Middle East and Africa will proliferate by exhibiting a CAGR of 39.84% in the forecast period 2019-2027, as stated by the author’s report. Saudi Arabia, the UAE, Turkey, South Africa and countries in rest of MEA together form the market for DNA vaccines in the Middle East and African region. South Africa’s pharmaceutical market is the largest and most developed in Sub-Saharan Africa, reflected by the relatively high levels of multinational drugmaker activity and well-established domestic manufacturing in the region. The regulatory advancements will take time to materialize, and drugmakers are expected to face a number of headwinds due to a weak local currency and uncertain macroeconomic & political environment. While this is likely to weigh on investor perceptions, opportunities for foreign drugmakers to grasp a foothold in the market remain abundant, particularly in the generic medicines sector. There will be an increase in demand for prescription generic drugs, due to the rising incomes and the roll-out of national health insurance & better healthcare infrastructure. Factors such as government pricing policy focused on reducing costs; government procurement favoring domestic companies; lack of universal healthcare insurance and funding shortcomings in the public healthcare system; slow drug approvals process; and vast inequality between infrastructure and provision of care in the public & private sectors are restraining the development of the pharmaceuticals and healthcare market.

Competitive Outlook
The renowned companies in the market are Astellas Pharma, Inc., Eli Lilly and Company, GlaxoSmithKline, Inc., Madison Vaccines, Incorporated (MVI), Merial Limited (acquired by Boehringer Ingelheim), Sanofi, Vical, Incorporated and Zoetis, Inc.
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • Astellas Pharma, Inc.
  • Eli Lilly And Company
  • Eurogentec S.A.
  • Glaxosmithkline, Inc.
  • Merck & Co.
  • Novartis AG
  • MORE
1. Middle East and Africa DNA Vaccines Market - Summary

2. Industry Outlook
2.1. Market Definition
2.2. Porter's Five Forces Outlook
2.2.1. Threat of New Entrants
2.2.2. Threats of Substitute Product
2.2.3. Bargaining Power of Buyer
2.2.4. Bargaining Power of Supplier
2.2.5. Intensity of Competitive Rivalry
2.3. Vendor Scorecard
2.4. Value Chain Outlook
2.5. Key Insights
2.6. Regulatory Framework
2.7. Key Buying Outlook
2.8. Market Drivers
2.8.1. Surge in New Vaccine Development
2.8.2. Rise in the Usage of DNA Vaccines for Animal Healthcare
2.8.3. Rising Prevalence of Chronic and Infectious Diseases
2.9. Market Restraints
2.9.1. Lack of Legal and Ethical Framework
2.9.2. Stringent Government Regulations
2.10. Market Opportunities
2.10.1. Growing Demand for Gene Therapy
2.10.2. Steady Vaccines Are Easy to Store and Transport
2.10.3. Increasing Number of Clinical Trials on Humans
2.11. Market Challenges
2.11.1. Variation in the Regulatory Pathway and the Points of Consideration Regarding Environmental Valuation

3. DNA Vaccines Market Outlook - by Type
3.1. Animal DNA Vaccine
3.2. Human DNA Vaccine

4. DNA Vaccines Market Outlook - by Application
4.1. Human Disease
4.2. Veterinary Disease

5. DNA Vaccines Market Outlook - by Technology
5.1. Plasmid DNA Vaccines
5.2. Plasmid DNA Delivery

6. DNA Vaccines Market Outlook - by Region
6.1. Middle East and Africa
6.1.1. Saudi Arabia
6.1.2. Turkey
6.1.3. The United Arab Emirates
6.1.4. South Africa
6.1.5. Rest of Middle East & Africa

7. Competitive Landscape
7.1. Astellas Pharma, Inc.
7.2. Dendreon Corporation (Acquired by Sanpower Group)
7.3. Eli Lilly and Company
7.4. Eurogentec S.A.
7.5. Glaxosmithkline, Inc.
7.6. Inovio Pharmaceuticals, Inc.
7.7. Madison Vaccines, Incorporated (Mvi)
7.8. Merck & Co.
7.9. Merial Limited (Acquired by Boehringer Ingelheim)
7.10. Novartis AG
7.11. Sanofi
7.12. Vgxi
7.13. Vical, Incorporated
7.14. Xenetic Biosciences, Inc.
7.15. Zoetis, Inc.

8. Methodology & Scope
8.1. Research Scope
8.2. Sources of Data
8.3. Research Methodology

List of Tables
Table 1 Middle East and Africa DNA Vaccines Market 2019-2027 ($ Million)
Table 2 Intervention and Phase of Some Diseases/Conditions
Table 3 Middle East and Africa DNA Vaccines Market in Veterinary Diseases 2019-2027 ($ Million)
Table 4 Temperature Requirement in Preservation for Various Vaccines
Table 5 Approaches Being Tested to Enhance the Low Immunogenicity
Table 6 Clinical Trials on Humans Involving DNA Vaccines
Table 7 Middle East and Africa DNA Vaccines Market by Type 2019-2027 ($ Million)
Table 8 Middle East and Africa DNA Vaccines Market by Application 2019-2027 ($ Million)
Table 9 Middle East and Africa DNA Vaccines Market by Technology 2019-2027 ($ Million)
Table 10 Middle East and Africa DNA Vaccines Market by Country 2019-2027 ($ Million)

List of Figures
Figure 1 Middle East and Africa DNA Vaccines Market 2019-2027 ($ Million)
Figure 2 Value Chain Analysis for DNA Vaccine Industry
Figure 3 Middle East and Africa DNA Vaccines Market in Veterinary Diseases 2019-2027 ($ Million)
Figure 4 Clinical Trials of Gene Therapy
Figure 5 Middle East and Africa DNA Vaccines Market in Animal DNA Vaccines 2019-2027 ($ Million)
Figure 6 Middle East and Africa DNA Vaccines Market in Human DNA Vaccines 2019-2027 ($ Million)
Figure 7 Middle East and Africa DNA Vaccines Market Share by Application 2018 & 2027 (%)
Figure 8 Middle East and Africa DNA Vaccines Market in Human Diseases 2019-2027 ($ Million)
Figure 9 Middle East and Africa DNA Vaccines Market in Veterinary Diseases 2019-2027 ($ Million)
Figure 10 Middle East and Africa DNA Vaccines Market in Plasmid DNA Vaccines Technology 2019-2027 ($ Million)
Figure 11 Middle East and Africa DNA Vaccines Market in Plasmid DNA Delivery Technology 2019-2027 ($ Million)
Figure 12 Saudi Arabia DNA Vaccines Market 2019-2027 ($ Million)
Figure 13 Turkey DNA Vaccines Market 2019-2027 ($ Million)
Figure 14 The United Arab Emirates DNA Vaccines Market 2019-2027 ($ Million)
Figure 15 South Africa DNA Vaccines Market 2019-2027 ($ Million)
Figure 16 Rest of Middle East & Africa DNA Vaccines Market 2019-2027 ($ Million)
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
  • Astellas Pharma, Inc.
  • Dendreon Corporation (Acquired By Sanpower Group)
  • Eli Lilly And Company
  • Eurogentec S.A.
  • Glaxosmithkline, Inc.
  • Inovio Pharmaceuticals, Inc.
  • Madison Vaccines, Incorporated (Mvi)
  • Merck & Co.
  • Merial Limited (Acquired By Boehringer Ingelheim)
  • Novartis AG
  • Sanofi
  • Vgxi
  • Vical, Incorporated
  • Xenetic Biosciences, Inc.
  • Zoetis, Inc.
Note: Product cover images may vary from those shown
Adroll
adroll